Cassava Sciences (SAVA) announced the retirement of James Kupiec, chief medical officer, effective May 9. The company also appointed Jack Moore as senior VP, clinical development, reporting to Rick Barry, CEO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SAVA:
- Biotech Alert: Searches spiking for these stocks today
- Cassava Sciences announces Phase 3 REFOCUS-ALZ did not meet primary endpoint
- Cassava Sciences to resume trading at 8:35 am ET
- Cassava Sciences to discontinue all efforts to develop simufilam in Alzheimer’s
- Cassava Sciences down 12% after simufilam doesn’t hit Alzheimer’s trial endpoint